Ovation.io and Illumina Collaborate to Advance Genomic Data Research
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Business Wire
PORTLAND, Maine--(BUSINESS WIRE)--Ovation.io, Inc., an organization dedicated to building best in class multi-omics datasets, today announced a collaboration with Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, that will work to accelerate advancements in precision medicine. The collaboration will address challenges in drug development by harnessing the power of genomic data to enable the discovery of drug targets coupled with biomarkers that increase the probability of success and decrease the cost of development.The focus of the collaboration will be on non-oncology indications where there are insufficient clinico-genomic datasets to advance genomically-based research goals. The collaboration will leverage Illumina’s next-generation sequencing (NGS) platforms alongside Ovation’s biobank, that contains 1.6+ million de-identified, consented and tokenized samples, with the goal of providing life sciences researchers with high-quality g
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Macrogen Consortium win tender for National Bio Big Data Project [Yahoo! Finance]Yahoo! Finance
- Macrogen Consortium win tender for National Bio Big Data ProjectPR Newswire
- Is There Now An Opportunity In Illumina, Inc. (NASDAQ:ILMN)? [Yahoo! Finance]Yahoo! Finance
- MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed [Yahoo! Finance Canada]Yahoo! Finance Canada
- Illumina, Inc. (NASDAQ: ILMN) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $165.00 price target on the stock, down previously from $190.00.MarketBeat
ILMN
Earnings
- 11/4/24 - Beat
ILMN
Sec Filings
- 1/2/25 - Form 4
- 12/9/24 - Form 4
- 12/6/24 - Form SC
- ILMN's page on the SEC website